SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,732,784 | +13.6% | 22,544 | +7.3% | 0.02% | +15.0% |
| Q2 2023 | $2,405,607 | -23.8% | 21,006 | -8.2% | 0.02% | -28.6% |
| Q1 2023 | $3,155,067 | +9.5% | 22,891 | +2.9% | 0.03% | 0.0% |
| Q4 2022 | $2,881,730 | +15.4% | 22,239 | -1.5% | 0.03% | +7.7% |
| Q3 2022 | $2,497,000 | +48.6% | 22,589 | +0.8% | 0.03% | +62.5% |
| Q2 2022 | $1,680,000 | -3.8% | 22,418 | +0.3% | 0.02% | +14.3% |
| Q1 2022 | $1,747,000 | -5.0% | 22,361 | +9.5% | 0.01% | 0.0% |
| Q4 2021 | $1,838,000 | -3.7% | 20,415 | -1.1% | 0.01% | -12.5% |
| Q3 2021 | $1,909,000 | +19.8% | 20,643 | +0.7% | 0.02% | +23.1% |
| Q2 2021 | $1,594,000 | -1.1% | 20,509 | -5.1% | 0.01% | -7.1% |
| Q1 2021 | $1,611,000 | -55.8% | 21,615 | +1.1% | 0.01% | -57.6% |
| Q4 2020 | $3,646,000 | +15.2% | 21,386 | -5.1% | 0.03% | +6.5% |
| Q3 2020 | $3,166,000 | +14.7% | 22,543 | +31.0% | 0.03% | -20.5% |
| Q2 2020 | $2,760,000 | +64.5% | 17,211 | +0.3% | 0.04% | +34.5% |
| Q1 2020 | $1,678,000 | – | 17,154 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |